The cushing's syndrome treatment is dependent on the cortisol levels, and can include various forms such as surgery resection, chemotherapy, radiation therapy and even the administration of the cortisol-inhibiting drugs, so that the pituitary adenoma or the adrenal adenoma in the body can be effectively dealt with.

Cushing's syndrome treatment in case of Pituitary adenomas: Although there are many therapies for treating the ACTH-producing pituitary adenoma of the Cushing’s disease, the most commonly used treatment is the surgical resection of the adenoma which is called the transsphenoidal adenomectomy.

This type of treatment is done through nostrils or by an opening in the upper lip, and this treatment is generally a delicate procedure overall, but with the doctors’ exclusive experiences; the success rate to remove the pituitary adenoma can be above 80%.

Radiation therapy is another form of effective treatment to deal with pituitary adenoma causing Cushing’s syndrome which is done over 6-week duration, with success rate of 40 to 50% in adults and upto 80% in children.

But it may take many months or years to recover while using this type of treatment to cure pituitary adenoma.

The radiation coupled with drug mitotane can encourage speedy recovery from the tumor, where mitotane alone can contribute to 30 to 40% of the success rate.

Cushing's syndrome treatment of the Ectopic ACTH: This deals with the excess production of the cortisol caused by the ectopic ACTH syndrome and treats with surgery, chemotherapy, immunotherapy, radiotherapy, or a combination of any the treatments depending on the type and extent of the cancer.

The mitotane can be a significant player in treating the adenoma.

Cushing's syndrome treatment of Adrenal tumors: Surgical removal of the adrenal glands to treat the benign as well as malignant tumors is the most viable option.

No disease can be properly cured or treated unless it is diagnosed properly by analyzing the patient’s medical history, his body’s physical structure, and the laboratory tests and results. The same is in the case of cushing's syndrome diagnosis.

Infact, while assessing the pituitary adenoma resulting in it and hence going through cushing's syndrome diagnosis, it is also helpful to examine the X-ray reports of the pituitary or the adrenal glands to check for the possibility of the pituitary adenoma in the body.

Moreover, these diagnoses reports assist the doctors in determining the cortisol levels in the patient and the reason for their variation.

Therefore, a review of some of the diagnostic tests can be really helpful in carrying out this task.

• 24-hour Urinary Free Cortisol level – Being one of the most specific diagnostic tests, in this type of diagnosis, the urine of the patient is collected and examined to check for the cortisol level. If the levels are more than 50-100 micrograms per day in an adult, then the cushing's syndrome diagnosis can be marked positive

• Dexamethasone Suppression Test – This distinguishes between the patients with surplus production of the ACTH hormone of the pituitary adenoma from the ectopic ACTH-secreting adenoma, through a synthetic glucocorticoid called dexamethasone which is administered to the patient every 6 hours for 4 days.

• Radiologic Imaging of the endocrine glands – The MRI and the CT scans are the most useful therapies in detecting the presence of the pituitary adenoma and its size and shape. But they are not used in the case of the benign tumors of the Cushing’s syndrome due to their lower activity in the region. Cushing's syndrome diagnosis indicates positive presence.

• Sampling of Petrosal Sinus – Though not required always, but it efficiently differentiates the causes of the pituitary from that of the ectopic of Cushing’s syndrome, by drawing blood from the petrosal sinuses.

• CRH Stimulation Test – With the help of the CRH (corticotropin-releasing hormone) injection, this helps in distinguishing patients suffering from the pituitary adenoma from those with ectopic ACTH disease or the cortisol-producing adrenal adenoma.

One of the famous and rare cases of the pituitary adenoma is the hormonal disorder in the body namely the Cushing's syndrome, which is caused due to high levels of the hormone ‘cortisol’ being secreted from the pituitary gland.

Often called as the “hypercortisolism” and affecting about 10 to 15 people in every 1,000,000 people, it is relatively rare and usually affects the people in the age group 20-50.

The symptoms of Cushing's syndrome vary from individuals to individuals depending on the size of the pituitary adenoma.

The body obesity, increased fat around the neck region, emaciating legs and arms, bulgy face are the most common symptoms found in the people, and in children, it is about obesity along with slow growth rate.

Symptoms can also be visible in the skin making the skin fragile and thin, with more bruises and lower healing rate.

There can be stretch marks on thighs, butts, breasts, arms and abdomen, which are purplish pink in color.

The spinal and rib fractures, and backaches due to routine activities are also associated with the occurrence of the pituitary adenoma while secreting the cortisol hormone, and thus making the bones in the body weak and fragile.

People often complain of severe fatigue, high blood pressure and sugar, anxiety, depression, weak muscles, irritability, etc. when affected with this kind of pituitary adenoma.

One can witness the unusual hair growth on a woman’s face, chest, thighs, neck, and abdomen together with the possibility of irregular menstrual cycles.

The pituitary adenoma in the Cushing's syndrome equally affects men in this regard by making their interest in sex low or completely absent.

What causes Cushing's syndrome?

When the tissues in the body are exposed to higher cortisol levels for a longer period of time, Cushing’s syndrome of the pituitary adenoma starts getting formulated.

Most people are affected with this disease more especially when they start taking glucocorticoid hormones such as prednisone for rheumatoid arthritis, asthma, and various other inflammatory diseases.

But the other most common reason for Cushing's syndrome to occur is the excess secretion of the cortisol hormone in the body.

Analyzing the production of the cortisol in the body, it performs the vital functions in the body ranging from maintaining the body blood pressure, balancing the insulin effects, regulating the metabolism rate for proteins and carbohydrates, reducing the inflammatory response of the body’s immune system, and monitoring the cardiovascular function in the body.

But when there are variations in the levels of this hormone, the hypothalamus and the pituitary gland secrete less CRH (corticotropin releasing hormone) and the ACTH (adrenocorticotropin hormone) leading to the formation of the pituitary adenoma for the Cushing's syndrome.

The pituitary adenoma is the major reason in most of the Cushing's syndrome cases, and it is usually benign and affects women more frequently than men, the ratio being 5:1. The other causes can be

• The Ectopic ACTH Syndrome that originates outside the pituitary producing ACTH and resulting in lung tumors in over 50% of the reported cases.
• Adrenal pituitary adenoma which is the result of the abnormality in the adrenal glands causing Cushing's syndrome, and mostly involving non-cancerous tumors called adrenal adenomas.
• Familial Cushing’s Syndrome that is the inherited case in a person for the development of the tumor of one of more endocrine glands, resulting in Cushing’s disease. Also, the hormone secreting adenomas of the pituitary or the parathyroid glands occur in MEN I type (multiple endocrine neoplasia type I), and the pituitary adenoma or the ectopic or the adrenal tumors cause the Cushing's syndrome to come in MEN I type.

Although there have been researches that are being consistently done to detect the causes of the occurrence of the prolactinoma of the pituitary adenoma, but the sources to actually detect their causes remain unknown.

Many of the instances are the ones where the pituitary adenoma appears sporadically in a person i.e. without any hereditary characteristics or any record being reported in the family of the person being affected by the pituitary adenoma.

There have been cases where some of the prolactinoma patients already have a genetic disorder which is called the multiple endocrine neoplasia type I (MEN I).

This is basically a condition of the pituitary adenoma where in the patient inherently gets the disorder because of the higher frequency of the occurrence of the peptic ulcer and the abnormal secretion of the hormones in the body which are produced from the pancreas, pituitary glands and the parathyroid.

Hence, the prolactinoma are the resultant feature of this MEN I disorder. But the people who have tendency to develop the prolactinoma need not necessarily have MEN I, as the specific genes in such cases are not yet fully detected.

Coming to the symptoms associated with prolactinoma, there are variations in the type of symptoms occurring in men and women.

In women, the high prolactin levels interrupt the ovulation, resulting in infertility, changes in menstrual cycles, production of breast milk in non breastfeeding mothers, loss of libido, and painful intercourses due to dryness in the vaginal region.

In men, the most common type is impotency followed by the visual problems, and loss of libido. But on an average, men tend to get larger prolactinoma of the pituitary adenoma than their female counterparts.

Diagnosis of the Prolactinoma and its Follow-up tests

The diagnosis of the prolactinoma is very important in order to detect its presence in the human body, and the elevations of this hormone called prolactin are normally detected by a simple blood test.

Though various indications of the prolactin level in men and women show the most common symptoms of infertility, galactorrhea (unexplained milk secretion in men and in non breastfeeding mothers), sexual dysfunctioning, etc, but if the prolactin secretion is much higher, then the functioning of the thyroid will be determined to gauge the effect of the pituitary adenoma.

Measuring and diagnosing the prolactinoma is effectively done through MRI (magnetic resonance imaging) and CT (computer tomography) scans, which provide a good picture of the pituitary adenoma.

Of the both, the magnetic resonance imaging is most sensitive to the test to check out the presence of the pituitary adenoma, as MRI scans may be repeated frequently to analyze the growth of the pituitary adenoma and the overall impact of the therapy.

Additionally, doctors also assess the tumor size on the MRI scan, to check out for the effect of the disease on the surrounding areas.

Follow-up tests post diagnosis:

Additional tests are often done after the main diagnosis of the pituitary adenoma for the assessment of the prolactin levels secreting from the pituitary gland.

This most commonly includes the eye test to examine the various visual fields, as the optic nerves are found in closer proximity to the pituitary gland and any extra growth of the pituitary gland can result in impingement on these optic nerves.

The 50 percent of the tumors occurring in the major and the minor salivary glands are related to the pleomorphic adenoma.

The pleomorphic adenoma accounts to about 70 percent of the tumors in the minor salivary glands, where it is widely found in the intraoral site which is the palate.

The upper lip and the buccal mucosa follow the intraoral site. This pleomorphic adenoma appears to be a painless structure initially and does not result in the ulceration of the overlying mucosa.

Hence, it appears to be mobile except when it appears in the hard palate. About 25 percent of the benign mixed adenomas transform themselves into malignant adenomas.

Considering the large soft palate tumor, this intraoral mixed tumor can be well encapsulated often leading to symptoms of the abnormal speech and dysphagia.

When the pleomorphic adenoma, a benign heterogeneous tumor, occurs in the soft palate region, the palatal tumor is usually a slow growing and painless mass for several years unless it becomes big enough to badly affect the respiration or the mastication.

Preoperatively, the Magnetic Resonance Imaging (MRI) technique is the way to confirm the presence of the pleomorphic adenoma of the soft palate which usually does not extend itself to the parapharyngeal space from the oropharynx.

Hence, to rule out the parapharyngeal space origin or extension, imaging is preferably done before attempting the transoral surgical approach.

In this case, it is better to proceed for external approach to get better picture and have good control over the regional cranial nerves and the vessels around.

The complete surgical excision is the best treatment choice to deal with the disease of the giant pleomorphic adenoma of the soft palate.

Post surgery, the patients regain their normal speech and swallowing abilities and there need not be any prominent changes in the soft-palate anatomy.

The pleomorphic adenoma of the skin which is also called as the chondroid syringoma where the eyelid is concerned is a very rare kind of adenoma.

Having eccrine or apocrine differences, the cases reported for this kind of adenoma have actually been mentioned in the Indian literature.

Normally being encapsulated, the sweat gland tumors are basically solitary and usually benign in nature while appearing to be hard circumscribed masses in the skin.

They mainly grow slowly and asymptomatically, but at the same time adopting a good size with the polypoid term.

The pleomorphic adenoma of the eyelid is one of the rarest cases that is come across by the researchers or even the surgeons, as its incidence being only 0.48% reportedly.

This is from the inference of a research on 207 cases of tumors where only one case of a tumor like lesion of the eyelid was reported.

The term chondroid syringoma was introduced by Hirsch and Helwig in 1961 to replace the pleomorphic adenoma or the mixed tumor of the skin, because of the epithelial nature that arise from the components of the sweat gland along with the secondary changes in the stroma which resembles a cartilage.

This pleomorphic adenoma of the eyelid apart from being asymptomatic, also show well-circumscribed structure in the skin which lies in the size range 0.3 mm – 0.5 mm in diameter.

There are two types of chondroid syringoma or the pleomorphic adenoma of the eyelid based on the morphological picture.

The first type can be the tubular, branching lumina and the second type is the small tubular lumina where glands are arranged in single layer of flat epithelial cells.

The pleomorphic adenoma of the skin involving eyelid can have either eccrine or apocrine components, and very rarely transforms into malignancy bringing widespread metastases.

Carcinoma ex Benign Pleomorphic Adenoma of the Parotid Gland

If the pleomorphic adenoma of benign nature is not treated well, then it leads to transform itself into a malignant tumor called the carcinoma ex benign pleomorphic adenoma, and this if formed in the parotid gland is called the carcinoma ex benign pleomorphic adenoma of the parotid gland. Histologically speaking, the diagnosed carcinoma of the pleomorphic adenoma is actually a subtype of the primary parotid malignancy.

According to researches, the features of the already treated salivary pleomorphic adenoma has got 25% of the cases with malignancy showing the nonspecific characteristics overall.

The preoperative investigations comprise of the fine-needle aspiration cytology (which shows low sensitivity for this adenoma), CT scans and the MRI scans, and the post treatment effects show the resection of the facial nerves en bloc with the tumor in some cases and good reconstruction of the recent-onset facial paresis in the other cases.

Usually about 44% of the patients have a complete histologic removal of the tumor and this refers to the most significant survival rate.

But the locoregional control rate for the carcinoma pleomorphic adenoma is only 66% in the 5-year duration of the recovery time making the recurrence of the disease invariably fatal, and even the 44% of the disease-specific specific cases report to high rate of mortality accounting to 87%.

Also, the carcinoma in the pleomorphic adenoma of the parotid gland is actually difficult to be diagnosed in the preoperative stages, and despite of the good control of the locoregional disease through surgery and the radiotherapy, the carcinoma ex benign pleomorphic adenoma delivers a high disease-specific mortality rate.

Observing the most significant prognostic factor due to the incomplete surgery resection, surgeons advocate some effective alternatives like radical ablative surgery, the imminent reconstruction of the soft tissue and the nerves, and a good index of clinical suspicion in order to avoid the development of the carcinoma in the pleomorphic adenoma of the parotid gland.

When the benign pleomorphic adenoma transforms into a malignant tumor, then a carcinoma ex pleomorphic adenoma (CXPA) is formed.

The carcinoma ex pleomorphic adenoma contains the malignant epithelium (salivary duct carcinoma, nonspecific adenocarcinoma, terminal duct carcinoma, undifferentiated carcinoma, or myoepithelial carcinoma) along with the benign stroma.

This carcinoma ex pleomorphic adenoma is an aggressive type of the pleomorphic salivary adenoma or the salivary gland malignancy, and rarely occurs in the salivary gland. And the direct cavernous sinus (CS) invasion of the soft palate is also an extremely rare case, and usually a biopsy of the soft palatal tumor displays the presence of the pleomorphic adenoma.

The differential diagnosis of the possibility of the presence of the pleomorphic adenoma as carcinoma is mostly done through the radio imaging therapies, where the Magnetic Resonance Imaging (MRI) scans show the tumor having the left maxilla, being stretched to the cavernous sinus (CS) from the pterygopalatine fossa and the inferior orbital fissure.

It is only after the surgery excision of the tumor, that the CXPA gets revealed. And the patients are also advocated the adjuvant concomitant chemo-radiation therapy (CCRT) for the treatment.

The recurrence of the tumor of the pleomorphic adenoma is possible again 5 months after the treatment in the left carvenous sinus has been done with the CCRT therapy.

The status of the disease is usually stable even after two years of the diagnosis of the CXPA. Doctors say that the patient with pleomorphic adenoma or the carcinoma symptoms like proptosis, facial numbness and the blurred vision must be observed vigilantly for the tumor invading the carvenous sinus from the perineural spread.

Pleomorphic Adenoma occurring in the Base of the Tongue

The common occurrence site for the pleomorphic adenoma is the palate in the minor salivary glands. Though the most common sites for its occurrence are the major salivary glands, but in the case of the minor salivary glands, a very few instances were revealed involving the tongue base and the subsequent valleculae.

The pleomorphic adenoma tumors consist of 3% of all the neoplasms, and in the minor salivary glands it is in the range 9%-22%. The malignant tumors in the tongue region occur more often, and they are usually the adenoid cystic carcinoma, the adenocarcinoma, and the mucoepidermoid carcinoma.

But the overall occurrence of the pleomorphic adenoma of the base of the tongue can be diagnosed when there is a routine examination of the patient or the worsening dysphagia.

The demographic information includes the average age of 50 years in a person for the occurrence of the pleomorphic adenoma where the ratio of the males to females is 1:1.

The histopathological manifestations of the pleomorphic adenoma of this kind also include the epithelial and the myoepithelial components.

The MRI (magnetic resonance imaging) is the effective way to deal with the nature and the extent of the tumor which also involves the lymph nodes and the affected regions around the tumor.

The treatment of the pleomorphic adenoma of the base of the tongue is basically surgical and is dependent on various factors such as the size and the location of the tumor and the age of the patient. The recurrence rate is 6% when the tumor is benign.

Middle Ear Pleomorphic Adenoma is the Extreme Case

The occurrence of the pleomorphic adenoma in the middle ear region is an extremely rare case. The mixed tumor developing in the ear is already a rare disease but in the middle ear, it is very rare.

Though the diagnosis, treatment and the prognosis of the disease have not been reported much, but the recurrence of the pleomorphic adenoma of the middle ear is reported.

Histopathologically, the pleomorphic adenoma contains the glandular epithelial and the myoepithelial components, but immunohistochemically, it shows a focal spread of the possibility to spread to the cytokeratin and s100 protein in the epithelial and the mesenchymal elements of the neoplasm.

Comparatively, the immunohistochemistry show more significance in diagnosing the formulation of the tumor in the middle ear, as the middle ear exhibits a single layer of the epithelial cells and does not have the myoepithelial component.

According to recent studies, the pleomorphic adenoma in the middle ear has got both the epithelial and the neuroendocrine elements also.

As said earlier, the pleomorphic adenoma rarely occurs in the ear, but is mainly seen in the external auditory canal. The pleomorphic adenoma of the middle ear possibly has three locations of formulation namely the ceruminal glands of the external auditory canal, metaplasia of the middle ear mucosa or the ectopic salivary gland.

Of all these places of origin, the pleomorphic adenoma is formed mainly from the ectopic salivary gland tissues.

Since mostly the lesions are localized and non-invasive, the immunohistochemistry is most significant in diagnosing the definite presence of the middle ear pleomorphic adenoma.

It is also not unnoticeable that the tumor recurs after 20 years post resection; hence, postoperatively the follow-ups are important, along with the resection at the recurrence which is effective in dealing with the middle ear pleomorphic adenoma.

Brucellosis abortus are small sized, gram negative micrococcus bacteria that cause brucellosis in animals. It is also referred to as zoonosis called brucellosis in animals. The disease is also known as Bang’s disease in cattle.

It causes Malta fever that is also symptomized by clinical presentation of undulant fever in the cattle. Brucellosis is transferred to human when the brucellosis abortus that is found in animals infects the humans.

The primary cause of infection is the ingestion of the disease causing bacteria brucella abortus by the humans. This occurs when infected humans come in contact with body fluids and tissues of the infected cattle.

In most cases, the brucellosis abortus may enter the body of the host through cuts and mucus membranes. They are known to infect phagocyte lyses found in the humans and release the bacteria brucellosis abortus in the blood. The bacteria are known to lodge itself in the spleen, liver, bone marrow and kidneys.

They are known to cause lesions in the infected organs of the host body. Some of the common symptoms that are associated with brucellosis include recurrent fever, chills, sweating and headaches and muscle pains in the body.

When the infection occurs in the cattle, it may cause abortion of fetus. When brucellosis abortus is found in animals, the animal is slaughtered in order to avoid the spread of the disease.

However, it has been found that some animals may be infected but they do not show any symptoms of infection and this is major cause for the spread of the disease.

According to a medical journal, a detailed survey of the symptoms of chronic brucellosis was conducted based on observations of veterinary surgeons working in different regions.

The observations were mainly conducted based on the symptoms during observation of cattle that were infected with brucella.

The common symptoms observed in chronic brucellosis included excessive sweating and weakness.

Most of the patients show symptoms of malaise and irritability and depression. In case of chronic brucellosis, there were signs of rheumatism and arthritis.

The veterinary doctors also reported the presence of backache which was very significant in the case of people infected with chronic brucellosis.

It was also found that common symptoms related to the alimentary canal were very much prevalent in all patients that were infected with brucellosis.

Headache and insomnia were found in chronic presentation of the disease. Furthermore, it was found that there was a high level of serological brucella antibody titers found in asymptomatic persons that were infected with chronic brucellosis.

In fact, it was found that a large number of surgeons show symptoms of the disease within a period of five years. Therefore, proper precautionary measures must be applied when dealing with infected cattle.

Brucellosis is known to be transmitted to human beings when it is ingested in the form of unpasteurized milk that may contain the bacteria. It can also be transferred when the veterinary surgeon or other workers come in contact with the body fluid or infected meat from the cattle showing symptoms of brucellosis.

The individual handling cattle must wear gloves and other gear that is used for protection in order to avoid direct contact with the carcass. After the procedure is completed, the gloves and all other gear must be burned in order to avoid spread of the disease.

The main objective of brucellosis medicine is to control the symptoms of brucellosis in humans. The brucellosis medicine is used in order to prevent the development of complications and relapses of the disease.

Brucellosis is known to have a high rate of relapses when immunotherapeutic approach is used. Therefore, the brucellosis medicine is based on multidrug antimicrobial approach where the risk of a relapse is highly reduced. The risk of a relapse is not easily determined and it is not a significant issue while treating brucellosis.

According to the World Health Organization, Doxycycline and rifampin are administered to the infected patients. The drugs are given on a regular basis for a period of 6 weeks and are known to increase a risk of a relapse.

In case of adults and children older than eight years, Doxycyline and streptomycin are administered in combination from 6 weeks to 3 weeks and this is a more effective form of brucellosis medicine and it does not cause any relapse.

In some cases, the physician may also substitute streptomycin with gentamicin and they are known to be equally effective.

It has been found that ciprofloxacin has shown equal effectiveness as compared to doxycycline based brucellosis medicine.

In case of children that are younger than eight years, medicines like rifamprin and trimethropin sulphamethozazole is used for 6 weeks and the relapse rates are known to be greatly reduced.

In case of pregnant women who are infected with brucellosis, the treatment is more complicated. Although vaccinations are available for controlling the spread of brucellosis in animals, there are no known vaccinations for humans.